663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1818608994203205632 |
---|---|
author | Faisal Khan Shameer Khader Youyi Zhang Daniel Jackson Kirsty Rhodes Imran Khan Anwer Neelufer Sreenath Nampally Andrzej Prokop Emmette Hutchison Jiabu Ye Feng Liu Antony Sabin James Weatherall Cristina Duran Renee Iacona Pralay Mukhopadhyay |
author_facet | Faisal Khan Shameer Khader Youyi Zhang Daniel Jackson Kirsty Rhodes Imran Khan Anwer Neelufer Sreenath Nampally Andrzej Prokop Emmette Hutchison Jiabu Ye Feng Liu Antony Sabin James Weatherall Cristina Duran Renee Iacona Pralay Mukhopadhyay |
author_sort | Faisal Khan |
collection | DOAJ |
first_indexed | 2024-12-16T14:51:29Z |
format | Article |
id | doaj.art-1db2c31bb5ed40ba9d561bb18d4f0cba |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-12-16T14:51:29Z |
publishDate | 2020-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-1db2c31bb5ed40ba9d561bb18d4f0cba2022-12-21T22:27:34ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0663663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysisFaisal Khan0Shameer Khader1Youyi Zhang2Daniel Jackson3Kirsty Rhodes4Imran Khan Anwer Neelufer5Sreenath Nampally6Andrzej Prokop7Emmette Hutchison8Jiabu Ye9Feng Liu10Antony Sabin11James Weatherall12Cristina Duran13Renee Iacona14Pralay Mukhopadhyay151AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA2AstraZeneca Pharma Poland, Warsaw, MD, Poland1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA1AstraZeneca, Gaithersburg, MD, USA |
spellingShingle | Faisal Khan Shameer Khader Youyi Zhang Daniel Jackson Kirsty Rhodes Imran Khan Anwer Neelufer Sreenath Nampally Andrzej Prokop Emmette Hutchison Jiabu Ye Feng Liu Antony Sabin James Weatherall Cristina Duran Renee Iacona Pralay Mukhopadhyay 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis Journal for ImmunoTherapy of Cancer |
title | 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis |
title_full | 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis |
title_fullStr | 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis |
title_full_unstemmed | 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis |
title_short | 663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis |
title_sort | 663 correlation between early endpoints and overall survival in non small cell lung cancer a trial level meta analysis |
work_keys_str_mv | AT faisalkhan 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT shameerkhader 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT youyizhang 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT danieljackson 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT kirstyrhodes 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT imrankhananwerneelufer 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT sreenathnampally 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT andrzejprokop 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT emmettehutchison 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT jiabuye 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT fengliu 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT antonysabin 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT jamesweatherall 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT cristinaduran 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT reneeiacona 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis AT pralaymukhopadhyay 663correlationbetweenearlyendpointsandoverallsurvivalinnonsmallcelllungcanceratriallevelmetaanalysis |